您的位置: 首页 > 农业专利 > 详情页

Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
专利权人:
GlaxoSmithKline Biologicals S.A.
发明人:
FERNANDEZ Fabiana,WETTER Michael,KOWARIK Michael,WACKER Michael
申请号:
SI200931870
公开号:
SI2257307T1
申请日:
2009.02.19
申请国别(地区):
SI
年份:
2018
代理人:
摘要:
The present invention is directed to a bioconjugate vaccine such as an O1-bioconjugate vaccine, comprising: a protein carrier comprising an inserted consensus sequence, D/E - X - N - Z - S/T, wherein X and Z may be any natural amino acid except proline; and at least one antigenic polysaccharide from at least one bacterium, linked to the protein carrier, wherein the at least one antigenic polysaccharide is a bacterial O-antigen from one or more strain of Shigella, E. coli or Pseudomonas aeruginosa; and, optionally, an adjuvant. In another aspect of the present invention is directed to a method of producing a O1- bioconjugate in a bioreactor comprising a number of steps.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充